Drug & Medication
Table of Contents
Includes 3 FREE quarterly updates BMI View: Given the country’s increasingly ageing population and the consequential rise in noncommunicable diseases, Australia is a highly attractive place for multinational industry players despite lower growth potential compared to emerging industries. However, we caution that the government’s funding of the Pharmaceutical Benefits Scheme (PBS) may be unsustainable, compounded by a la...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Jordan
+1 917 267 7886
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...
PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of ...
... vaccination 1988: before the global polio eradication initiative endemic non-endemic who. Global polio eradication initiative. Available at: http ...
... External reference pricing (erp) middle income countries ask for a reduced price as well 34 4.4 Eu instruments contributing to global drug development, safety, quality and efficacy access to medicines ...
Reportlinker.com © Copyright 2014. All rights reserved.